Hypertension and Type 2 Diabetes

Patients with hypertension and diabetes are at high risk of cardiovascular events and several studies have looked at the use of MICARDIS^® and MICARDISPLUS^® in this clinical setting.

These include the DETAIL,¹INNOVATION,² AMADEO³and VIVALDI,⁴trials and the SMOOTH⁵and The ONTARGET^® Trial Programme.

Study of MICARDIS^® (telmisartan) in Overweight/Obese patients with Type 2 diabetes and Hypertension

Diabetics Exposed to Telmisartan And enalaprIL

A trial to compare telMisartan 40 mg titrated to 80 mg versus losArtan 100 mg in hypertensive Type 2 DiabEtic patients with Overt nephropathy

A trial to inVestigate the efficacy of telmIsartan 80 mg versus VALsartan 160 mg in hypertensive Type 2 DIabetic patients with overt nephropathy

INcipieNt to OVert Angiotensin II receptor blocker, Telmisartan, Investigation On type II diabetic Nephropathy

ONgoing Telmisartan Alone in combination with Ramipril Global Endpoint Trial